Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment

EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.

Trial Details

NCT ID
NCT06354738
Phase
NA
Sponsor
University Hospital, Gasthuisberg
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • total hysterectomy with bilateral salpingo-oophorectomy, lymph node staging and comprehensive peritoneal staging
Locations (sample)
  • Leuven, Belgium|50.87959,4.70093

Key Eligibility Criteria

  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained before any screening procedures
  • Women ≥ 18 years
  • First diagnosis of EC, all disease stages and all histo-types

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →